D

DaVita
D

DVA

138.230
USD
-0.23
(-0.17%)
مغلق
حجم التداول
20,223
الربح لكل سهم
11
العائد الربحي
-
P/E
14
حجم السوق
10,447,008,710
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
BAX
BAX
-0.165
(-0.55%)
30.110 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
DGX
DGX
1.620
(0.96%)
171.200 USD
DHR
DHR
-2.900
(-1.55%)
184.570 USD
HCA
HCA
-0.20
(-0.05%)
376.63 USD
LH
LH
0.680
(0.28%)
242.510 USD
SYK
SYK
-1.79
(-0.47%)
376.66 USD
UNH
UNH
-4.34
(-1.45%)
295.57 USD
المزيد
الأخبار المقالات

العنوان: DaVita

القطاع: Healthcare
الصناعة: Medical Care Facilities
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.